1. Home
  2. SHBI vs LBRX Comparison

SHBI vs LBRX Comparison

Compare SHBI & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

HOLD

Current Price

$19.19

Market Cap

636.2M

Sector

Finance

ML Signal

HOLD

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$30.31

Market Cap

602.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHBI
LBRX
Founded
1876
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
636.2M
602.6M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
SHBI
LBRX
Price
$19.19
$30.31
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$19.17
$46.60
AVG Volume (30 Days)
228.2K
299.4K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
2.45%
N/A
EPS Growth
34.85
N/A
EPS
1.78
N/A
Revenue
$20,853,000.00
N/A
Revenue This Year
$8.97
N/A
Revenue Next Year
$6.26
N/A
P/E Ratio
$10.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.67
$13.40
52 Week High
$20.68
$33.47

Technical Indicators

Market Signals
Indicator
SHBI
LBRX
Relative Strength Index (RSI) 51.13 60.06
Support Level $18.88 $21.90
Resistance Level $19.31 N/A
Average True Range (ATR) 0.50 2.05
MACD -0.04 0.15
Stochastic Oscillator 21.00 67.10

Price Performance

Historical Comparison
SHBI
LBRX

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

Share on Social Networks: